Ariela Rivkah Orkaby, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Veterans | 22 | 2024 | 2631 | 4.740 |
Why?
|
Frail Elderly | 23 | 2024 | 752 | 3.000 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 15 | 2024 | 3227 | 2.950 |
Why?
|
Cardiovascular Diseases | 23 | 2024 | 15396 | 2.170 |
Why?
|
Primary Prevention | 7 | 2024 | 1185 | 2.150 |
Why?
|
Yoga | 3 | 2023 | 281 | 2.010 |
Why?
|
Geriatric Assessment | 18 | 2024 | 1404 | 1.950 |
Why?
|
Nails | 3 | 2021 | 295 | 1.230 |
Why?
|
Geriatrics | 6 | 2024 | 387 | 1.150 |
Why?
|
Aged | 83 | 2024 | 168217 | 1.100 |
Why?
|
Dementia | 5 | 2024 | 2650 | 0.900 |
Why?
|
Atherosclerosis | 4 | 2024 | 3401 | 0.890 |
Why?
|
Stroke | 7 | 2023 | 9696 | 0.840 |
Why?
|
Aspirin | 3 | 2024 | 3132 | 0.810 |
Why?
|
Advance Directives | 1 | 2024 | 248 | 0.810 |
Why?
|
Terminology as Topic | 3 | 2019 | 1533 | 0.800 |
Why?
|
Meditation | 1 | 2023 | 251 | 0.720 |
Why?
|
Postural Balance | 2 | 2021 | 617 | 0.700 |
Why?
|
Tai Ji | 1 | 2023 | 287 | 0.690 |
Why?
|
Myocardial Infarction | 7 | 2023 | 11424 | 0.660 |
Why?
|
Task Performance and Analysis | 1 | 2023 | 759 | 0.640 |
Why?
|
Hospitals, Veterans | 1 | 2021 | 395 | 0.630 |
Why?
|
Cholesterol | 5 | 2024 | 2901 | 0.620 |
Why?
|
Humans | 102 | 2024 | 758381 | 0.590 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2024 | 2270 | 0.590 |
Why?
|
Mobility Limitation | 1 | 2021 | 400 | 0.580 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2023 | 985 | 0.580 |
Why?
|
Hypercholesterolemia | 1 | 2024 | 1139 | 0.580 |
Why?
|
Independent Living | 2 | 2019 | 567 | 0.570 |
Why?
|
Defibrillators, Implantable | 2 | 2024 | 1487 | 0.550 |
Why?
|
Aged, 80 and over | 30 | 2024 | 58681 | 0.550 |
Why?
|
Pravastatin | 1 | 2018 | 392 | 0.540 |
Why?
|
International Classification of Diseases | 2 | 2021 | 892 | 0.540 |
Why?
|
Anticholesteremic Agents | 2 | 2024 | 963 | 0.520 |
Why?
|
Sulfonylurea Compounds | 1 | 2017 | 219 | 0.520 |
Why?
|
Heart Arrest | 2 | 2023 | 1494 | 0.490 |
Why?
|
Heart Failure | 10 | 2024 | 11594 | 0.490 |
Why?
|
Cholesterol, LDL | 1 | 2024 | 2374 | 0.480 |
Why?
|
Carotid Artery Diseases | 1 | 2021 | 872 | 0.480 |
Why?
|
Accidental Falls | 2 | 2021 | 1056 | 0.470 |
Why?
|
Atrial Fibrillation | 4 | 2024 | 5105 | 0.460 |
Why?
|
Executive Function | 1 | 2023 | 1375 | 0.460 |
Why?
|
Male | 52 | 2024 | 358742 | 0.460 |
Why?
|
Carotid Stenosis | 1 | 2021 | 853 | 0.450 |
Why?
|
Physicians | 2 | 2022 | 4581 | 0.450 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1705 | 0.440 |
Why?
|
Risk Assessment | 12 | 2024 | 23883 | 0.440 |
Why?
|
Mortality | 3 | 2021 | 2885 | 0.430 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 1373 | 0.420 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1386 | 0.420 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2023 | 2239 | 0.420 |
Why?
|
Health Status Indicators | 1 | 2018 | 970 | 0.420 |
Why?
|
Risk Adjustment | 1 | 2016 | 600 | 0.400 |
Why?
|
Female | 45 | 2024 | 390316 | 0.370 |
Why?
|
Influenza, Human | 1 | 2022 | 1516 | 0.370 |
Why?
|
Coronary Disease | 3 | 2023 | 5917 | 0.360 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1401 | 0.360 |
Why?
|
Physical Examination | 3 | 2023 | 1244 | 0.350 |
Why?
|
Research | 1 | 2019 | 1976 | 0.350 |
Why?
|
Risk Factors | 20 | 2024 | 73806 | 0.350 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2024 | 10146 | 0.340 |
Why?
|
Fellowships and Scholarships | 1 | 2018 | 1116 | 0.340 |
Why?
|
Metformin | 1 | 2017 | 907 | 0.340 |
Why?
|
Cardiology | 1 | 2021 | 1667 | 0.340 |
Why?
|
Inflammation | 3 | 2024 | 10719 | 0.330 |
Why?
|
Life Style | 2 | 2018 | 3886 | 0.330 |
Why?
|
Retrospective Studies | 17 | 2024 | 80170 | 0.330 |
Why?
|
United States | 23 | 2024 | 72140 | 0.330 |
Why?
|
Exercise | 3 | 2023 | 5788 | 0.320 |
Why?
|
Aging | 4 | 2023 | 8651 | 0.310 |
Why?
|
Warfarin | 1 | 2016 | 1482 | 0.310 |
Why?
|
Memory | 1 | 2018 | 2179 | 0.300 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7377 | 0.280 |
Why?
|
Preoperative Care | 1 | 2016 | 2249 | 0.280 |
Why?
|
Prosthesis-Related Infections | 1 | 2012 | 486 | 0.280 |
Why?
|
United States Department of Veterans Affairs | 5 | 2024 | 907 | 0.260 |
Why?
|
Vitamin D | 1 | 2019 | 3283 | 0.260 |
Why?
|
Prospective Studies | 11 | 2024 | 54136 | 0.250 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3069 | 0.240 |
Why?
|
Age Factors | 5 | 2024 | 18357 | 0.240 |
Why?
|
Proportional Hazards Models | 5 | 2019 | 12440 | 0.220 |
Why?
|
Life Expectancy | 3 | 2021 | 1244 | 0.220 |
Why?
|
Stroke Volume | 5 | 2023 | 5460 | 0.220 |
Why?
|
Institutionalization | 1 | 2023 | 105 | 0.220 |
Why?
|
Sodium | 2 | 2019 | 1588 | 0.220 |
Why?
|
Trail Making Test | 1 | 2023 | 57 | 0.210 |
Why?
|
Internship and Residency | 2 | 2024 | 5865 | 0.210 |
Why?
|
England | 1 | 2024 | 524 | 0.210 |
Why?
|
State Medicine | 1 | 2024 | 213 | 0.200 |
Why?
|
Dementia, Vascular | 1 | 2023 | 122 | 0.200 |
Why?
|
Anticoagulants | 2 | 2021 | 4778 | 0.200 |
Why?
|
Middle Aged | 20 | 2024 | 219560 | 0.200 |
Why?
|
Self Report | 2 | 2024 | 3712 | 0.190 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2012 | 1406 | 0.190 |
Why?
|
Medicare | 6 | 2024 | 6741 | 0.190 |
Why?
|
Propensity Score | 2 | 2020 | 1907 | 0.180 |
Why?
|
Nutrition Assessment | 1 | 2024 | 726 | 0.180 |
Why?
|
Time Factors | 7 | 2021 | 39873 | 0.180 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3603 | 0.180 |
Why?
|
Pituitary-Adrenal System | 1 | 2023 | 552 | 0.180 |
Why?
|
Adult Children | 1 | 2020 | 103 | 0.180 |
Why?
|
Hand Strength | 1 | 2023 | 452 | 0.170 |
Why?
|
Cohort Studies | 8 | 2023 | 41252 | 0.170 |
Why?
|
Hypolipidemic Agents | 1 | 2024 | 609 | 0.170 |
Why?
|
Ventricular Function, Left | 4 | 2023 | 3858 | 0.170 |
Why?
|
Health Status | 3 | 2021 | 4069 | 0.170 |
Why?
|
Skilled Nursing Facilities | 1 | 2024 | 394 | 0.170 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2023 | 700 | 0.170 |
Why?
|
Teaching Rounds | 1 | 2023 | 275 | 0.160 |
Why?
|
Coronary Artery Bypass | 3 | 2023 | 2189 | 0.160 |
Why?
|
Aortic Valve Stenosis | 2 | 2021 | 2002 | 0.160 |
Why?
|
Hospitals | 2 | 2023 | 3888 | 0.160 |
Why?
|
Rehabilitation Centers | 1 | 2020 | 247 | 0.160 |
Why?
|
Veterans Health | 1 | 2020 | 215 | 0.160 |
Why?
|
Feasibility Studies | 3 | 2023 | 5199 | 0.150 |
Why?
|
Dietary Supplements | 2 | 2022 | 3388 | 0.150 |
Why?
|
Drug Monitoring | 1 | 2024 | 960 | 0.150 |
Why?
|
Acetaminophen | 1 | 2022 | 552 | 0.150 |
Why?
|
Rehabilitation | 1 | 2019 | 129 | 0.150 |
Why?
|
Secondary Prevention | 1 | 2024 | 1475 | 0.150 |
Why?
|
Interleukin-1beta | 1 | 2023 | 996 | 0.150 |
Why?
|
Malnutrition | 1 | 2024 | 639 | 0.140 |
Why?
|
Hospital Mortality | 2 | 2022 | 5273 | 0.140 |
Why?
|
Cholecalciferol | 1 | 2022 | 549 | 0.140 |
Why?
|
Activities of Daily Living | 2 | 2023 | 2414 | 0.140 |
Why?
|
Longitudinal Studies | 4 | 2023 | 14481 | 0.140 |
Why?
|
Comorbidity | 3 | 2023 | 10495 | 0.140 |
Why?
|
Health Services for the Aged | 1 | 2019 | 259 | 0.140 |
Why?
|
Foot | 1 | 2020 | 573 | 0.130 |
Why?
|
Cognition | 3 | 2024 | 6955 | 0.130 |
Why?
|
Nursing Homes | 1 | 2024 | 1080 | 0.130 |
Why?
|
Lipid Metabolism | 1 | 2024 | 1894 | 0.130 |
Why?
|
Hospice Care | 1 | 2022 | 677 | 0.130 |
Why?
|
Ambulatory Care Facilities | 1 | 2021 | 927 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1793 | 0.110 |
Why?
|
Electronic Health Records | 2 | 2024 | 4761 | 0.110 |
Why?
|
Vitamins | 1 | 2022 | 1632 | 0.110 |
Why?
|
Prognosis | 6 | 2024 | 29558 | 0.110 |
Why?
|
Diabetes Mellitus | 3 | 2024 | 5818 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12076 | 0.110 |
Why?
|
Education, Medical, Continuing | 1 | 2018 | 827 | 0.110 |
Why?
|
Mentors | 1 | 2018 | 660 | 0.110 |
Why?
|
Data Mining | 1 | 2018 | 551 | 0.110 |
Why?
|
Cause of Death | 2 | 2022 | 3674 | 0.110 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 839 | 0.110 |
Why?
|
Treatment Outcome | 7 | 2023 | 64379 | 0.110 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 931 | 0.110 |
Why?
|
Drug-Eluting Stents | 1 | 2019 | 679 | 0.110 |
Why?
|
Diet, Mediterranean | 1 | 2019 | 736 | 0.100 |
Why?
|
Hyperlipidemias | 1 | 2018 | 771 | 0.100 |
Why?
|
Coronary Artery Disease | 2 | 2023 | 6363 | 0.100 |
Why?
|
Yogurt | 1 | 2012 | 71 | 0.100 |
Why?
|
Hospitalization | 5 | 2024 | 10653 | 0.100 |
Why?
|
Osteoporotic Fractures | 1 | 2017 | 408 | 0.100 |
Why?
|
Overweight | 1 | 2023 | 2410 | 0.100 |
Why?
|
Pilot Projects | 2 | 2024 | 8554 | 0.100 |
Why?
|
Confidence Intervals | 1 | 2017 | 2925 | 0.100 |
Why?
|
Vascular Surgical Procedures | 1 | 2020 | 1470 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2115 | 0.090 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1547 | 0.090 |
Why?
|
General Surgery | 1 | 2022 | 1677 | 0.090 |
Why?
|
Terminal Care | 1 | 2022 | 1750 | 0.090 |
Why?
|
Disease Progression | 2 | 2024 | 13468 | 0.090 |
Why?
|
Insulin Resistance | 1 | 2023 | 3941 | 0.080 |
Why?
|
Incidence | 2 | 2024 | 21273 | 0.080 |
Why?
|
Quality Improvement | 2 | 2021 | 3806 | 0.080 |
Why?
|
Linear Models | 1 | 2019 | 5861 | 0.080 |
Why?
|
Loneliness | 1 | 2011 | 196 | 0.080 |
Why?
|
Postoperative Complications | 2 | 2020 | 15638 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10505 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 3671 | 0.070 |
Why?
|
Case-Control Studies | 1 | 2024 | 22031 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1415 | 0.060 |
Why?
|
Quality of Life | 2 | 2021 | 13286 | 0.060 |
Why?
|
Registries | 1 | 2021 | 8176 | 0.060 |
Why?
|
Odds Ratio | 1 | 2017 | 9650 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3242 | 0.060 |
Why?
|
Decision Making | 1 | 2018 | 3915 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12721 | 0.060 |
Why?
|
Smoking | 1 | 2020 | 9042 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 25953 | 0.060 |
Why?
|
Nicotinamide Mononucleotide | 1 | 2023 | 17 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 3018 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12951 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39060 | 0.050 |
Why?
|
Adult | 5 | 2023 | 219916 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5403 | 0.050 |
Why?
|
Podiatry | 1 | 2020 | 28 | 0.040 |
Why?
|
Faculty | 1 | 2024 | 383 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8530 | 0.040 |
Why?
|
Polypharmacy | 1 | 2022 | 305 | 0.040 |
Why?
|
NAD | 1 | 2023 | 609 | 0.040 |
Why?
|
Patient Discharge | 2 | 2022 | 3433 | 0.040 |
Why?
|
Knowledge Bases | 1 | 2019 | 97 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8503 | 0.040 |
Why?
|
Needs Assessment | 1 | 2024 | 1141 | 0.040 |
Why?
|
Body Weight | 2 | 2023 | 4603 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 782 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 1808 | 0.040 |
Why?
|
Absorbable Implants | 1 | 2019 | 338 | 0.030 |
Why?
|
Prevalence | 3 | 2021 | 15646 | 0.030 |
Why?
|
Aftercare | 1 | 2022 | 910 | 0.030 |
Why?
|
Nutritional Status | 1 | 2024 | 1607 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2011 | 3362 | 0.030 |
Why?
|
Program Development | 1 | 2021 | 1297 | 0.030 |
Why?
|
Diuretics | 1 | 2018 | 610 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22030 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2022 | 2154 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 3993 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20052 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2011 | 5331 | 0.030 |
Why?
|
Databases, Factual | 2 | 2018 | 7980 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2019 | 1730 | 0.030 |
Why?
|
Sirolimus | 1 | 2019 | 1533 | 0.020 |
Why?
|
Lipids | 1 | 2023 | 3326 | 0.020 |
Why?
|
Polymers | 1 | 2019 | 1615 | 0.020 |
Why?
|
Aortic Valve | 1 | 2021 | 1950 | 0.020 |
Why?
|
Depression | 1 | 2011 | 8057 | 0.020 |
Why?
|
Death, Sudden, Cardiac | 1 | 2019 | 1554 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7023 | 0.020 |
Why?
|
Group Practice | 1 | 2011 | 151 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2018 | 1704 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2021 | 4451 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2018 | 1135 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2022 | 3586 | 0.020 |
Why?
|
Observation | 1 | 2011 | 311 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20500 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14641 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3570 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9599 | 0.020 |
Why?
|
Stents | 1 | 2019 | 3162 | 0.020 |
Why?
|
Primary Health Care | 1 | 2024 | 4653 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6439 | 0.020 |
Why?
|
Blood Pressure | 1 | 2022 | 8453 | 0.020 |
Why?
|
Echocardiography | 1 | 2018 | 4962 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2018 | 5098 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5070 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12262 | 0.020 |
Why?
|
Chronic Disease | 1 | 2019 | 9266 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 26182 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7810 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12870 | 0.010 |
Why?
|
Patient Compliance | 1 | 2011 | 2685 | 0.010 |
Why?
|
Qualitative Research | 1 | 2011 | 2976 | 0.010 |
Why?
|
Massachusetts | 1 | 2011 | 8823 | 0.010 |
Why?
|
Heart Diseases | 1 | 2011 | 2782 | 0.010 |
Why?
|
Pain | 1 | 2011 | 5065 | 0.010 |
Why?
|